A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology... von Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

Volltext

Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer von BEREK, Jonathan, TAYLOR, Peyton, MCGUIRE, William, SMITH, L. Mary, SCHULTES, Birgit, NICODEMUS, Christopher F

Volltext

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy von Marachelian, Araz, Desai, Ami, Balis, Frank, Katzenstein, Howard, Qayed, Muna, Armstrong, Michael, Neville, Kathleen A., Cohn, Susan L., Bush, Mark, Gunawan, Rudy, Lim, Allison Pecha, Smith, Malcolm A., Mary Smith, L.

Volltext

Patient perspectives on chemotherapy de‐escalation in breast cancer von Rocque, Gabrielle B., Williams, Courtney P., Andrews, Courtney, Childers, Timothy C., Wiseman, Kimberly D., Gallagher, Kathleen, Tung, Nadine, Balch, Alan, Lawhon, Valerie M, Ingram, Stacey A, Brown, Thelma, Kaufmann, Tara, Smith, Mary L., DeMichele, Angela, Wolff, Antonio C., Wagner, Lynne

Volltext

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors von Gounder, Mrinal, Ratan, Ravin, Alcindor, Thierry, Schöffski, Patrick, van der Graaf, Winette T., Wilky, Breelyn A., Riedel, Richard F., Lim, Allison, Smith, L. Mary, Moody, Stephanie, Attia, Steven, Chawla, Sant, D’Amato, Gina, Federman, Noah, Merriam, Priscilla, Van Tine, Brian A., Vincenzi, Bruno, Benson, Charlotte, Bui, Nam Quoc, Chugh, Rashmi, Tinoco, Gabriel, Charlson, John, Dileo, Palma, Hartner, Lee, Lapeire, Lore, Mazzeo, Filomena, Palmerini, Emanuela, Reichardt, Peter, Stacchiotti, Silvia, Bailey, Howard H., Burgess, Melissa A., Cote, Gregory M., Davis, Lara E., Deshpande, Hari, Gelderblom, Hans, Grignani, Giovanni, Loggers, Elizabeth, Philip, Tony, Pressey, Joseph G., Kummar, Shivaani, Kasper, Bernd

Volltext

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr... von Ozkaynak, M Fevzi, Gilman, Andrew L, London, Wendy B, Naranjo, Arlene, Diccianni, Mitchell B, Tenney, Sheena C, Smith, Malcolm, Messer, Karen S, Seeger, Robert, Reynolds, C Patrick, Smith, L Mary, Shulkin, Barry L, Parisi, Marguerite, Maris, John M, Park, Julie R, Sondel, Paul M, Yu, Alice L

Volltext

GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi rand... von Gounder, Mrinal M., Atkinson, Thomas M., Bell, Timothy, Daskalopoulou, Christina, Griffiths, Pip, Martindale, Moriah, Smith, L. Mary, Lim, Allison

Volltext

The epidemiology of desmoid tumors in Denmark von Anneberg, Marie, Svane, Helene M.L., Fryzek, Jon, Nicholson, Gina, White, Jessica B., Edris, Badreddin, Smith, L. Mary, Hooda, Naushin, Petersen, Michael M., Baad-Hansen, Thomas, Keller, Johnny Ø., Jørgensen, Peter H., Pedersen, Alma B.

Volltext

Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology von Itzstein, Mitchell S., Railey, Elda, Smith, Mary L., White, Carol B., Sledge, George W., Howell, John R., Lawton, Wendy, Marinucci, Donna M., Unni, Nisha, Gerber, David E.

Volltext

Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma von Desai, Ami V., Fox, Elizabeth, Smith, L. Mary, Lim, Allison Pecha, Maris, John M., Balis, Frank M.

Volltext

ICOS‐mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells von Vieira, Pedro L., Wassink, Lianne, Smith, L. Mary, Nam, Samuel, Kingsbury, Gillian A., Gutierrez‐Ramos, Jose Carlos, Coyle, Anthony J., Kapsenberg, Martien L., Wierenga, Eddy A.

Volltext

Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology? von von Itzstein, Mitchell S, Smith, Mary L, Railey, Elda, White, Carol B, Dieterich, Julianne S, Garrett-Mayer, Liz, Bruinooge, Suanna S, Freedman, Andrew N, De Moor, Janet, Gray, Stacy W, Park, Jason Y, Yan, Jingsheng, Hoang, Anh Quynh, Zhu, Hong, Gerber, David E

Volltext

Central institutional review board-facilitated review metrics omit critical components von Katz, Michael S, Smith, Mary L

Volltext

Abstract P5-15-07: Let's talk about it: Communicating about risk of recurrence in early-stage breast cancer von Smith, Mary L, Railey, Elda M, White, Carol B

Volltext

Population pharmacokinetic-pharmacodynamic model of nirogacestat effects on B-cell maturation antigen in healthy subjects von Shearer, Todd, Williams, Rex L., Johnson, Mark, Cendrowicz, Ewa, Leonowens, Cathrine, Smith, Margaret, Baughman, Todd, Breitbach, Caroline J., Smith, L. Mary, Cheng, Shinta

Volltext

Pharmacodynamic Effects of Nirogacestat, a Gamma Secretase Inhibitor, on B-Cell Maturation Antigen in Healthy Participants von Shearer, Todd, Williams, Rex L., Johnson, Mark, Cendrowicz, Ewa, Leonowens, Cathrine, Smith, Margaret, Baughman, Todd, Breitbach, Caroline J., Smith, L. Mary, Burgess, Michael, Cheng, Shinta

Volltext

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer von Schultes, Birgit C, Smith, L Mary, Nicodemus, Christopher F

Volltext

Abstract PS9-01: Consumer and patient reactions to trials of chemotherapy reductions reveal an urgent need to name and explain the concept von Smith, Mary L, Railey, Elda, White, Carol B, Hill, Janine, Andrews, Courtney J, Rocque, Gabrielle B

Volltext

Abstract 5775: Survey to identify current physician preferences for the treatment of patients with desmoid tumors von White, Jessica, Edris, Badreddin, Renstrup, Jens, Smith, L. Mary, Tumminello, Brad

Volltext

Role of monoclonal antibodies in tumor-specific immunity von Nicodemus, Christopher F, Smith, L Mary, Schultes, Birgit C

Volltext